Drug Profile
Research programme: analgesic therapeutics - Eurand
Latest Information Update: 14 Aug 2009
Price :
$50
*
At a glance
- Originator University of Milan; University of Sassari
- Developer Eurand; University of Milan; University of Sassari
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 27 Jan 2006 Preclinical trials in Pain in Italy (unspecified route)